MedTrace Logo

Loop Diuretic Therapy in Acutely Decompensated Heart Failure

NCT02638142 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2025-08-08

No results posted yet for this study

Summary

DiurHF is a prospective, multicenter, observational, study that compares continuous with intermittent infusion of furosemide in patients admitted with a diagnosis of ADHF. Previous pilot study design was planned to anticipate a larger multicenter trial able to definitively evaluate the optimal loop diuretic use strategy in patients with ADHF.

Conditions

  • Acute Heart Failure

Interventions

DRUG

Continuous Furosemide Infusion

Intravenous continuous Furosemide infusion

DRUG

Intermittent Furosemide Infusion

Intravenous bolus intermittent Furosemide Infusion

Sponsors & Collaborators

  • University of Roma La Sapienza

    collaborator OTHER

  • Ospedale Regina Montis Regalis

    collaborator OTHER

  • University of Naples

    collaborator OTHER

  • A.O.U. Città della Salute e della Scienza

    collaborator OTHER

  • University of Milan

    collaborator OTHER

  • University of Siena

    lead OTHER

Principal Investigators

  • Alberto Palazzuoli, MD · University of Siena

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02638142 on ClinicalTrials.gov